Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Electronic Health Records | 85 | 2024 | 4879 | 5.580 |
Why?
|
Information Storage and Retrieval | 29 | 2024 | 832 | 4.730 |
Why?
|
Medical Records Systems, Computerized | 18 | 2018 | 1196 | 2.100 |
Why?
|
Software | 27 | 2024 | 4464 | 2.020 |
Why?
|
Biomedical Research | 25 | 2024 | 3458 | 2.000 |
Why?
|
Algorithms | 51 | 2024 | 14071 | 1.990 |
Why?
|
Medical Informatics | 14 | 2022 | 744 | 1.980 |
Why?
|
Data Mining | 7 | 2021 | 560 | 1.950 |
Why?
|
Natural Language Processing | 27 | 2023 | 1203 | 1.920 |
Why?
|
Intracranial Aneurysm | 18 | 2024 | 1271 | 1.490 |
Why?
|
Systems Integration | 13 | 2017 | 425 | 1.470 |
Why?
|
Aneurysm, Ruptured | 13 | 2021 | 455 | 1.460 |
Why?
|
Information Dissemination | 8 | 2022 | 1142 | 1.270 |
Why?
|
Medical Record Linkage | 8 | 2021 | 286 | 1.200 |
Why?
|
Computer Communication Networks | 6 | 2019 | 292 | 1.180 |
Why?
|
Informatics | 3 | 2022 | 72 | 1.070 |
Why?
|
User-Computer Interface | 7 | 2017 | 1407 | 0.950 |
Why?
|
Forms and Records Control | 3 | 2008 | 158 | 0.890 |
Why?
|
Medical Informatics Applications | 2 | 2018 | 180 | 0.870 |
Why?
|
Diagnosis | 2 | 2021 | 157 | 0.850 |
Why?
|
Databases as Topic | 4 | 2014 | 472 | 0.810 |
Why?
|
Inflammatory Bowel Diseases | 14 | 2019 | 2432 | 0.810 |
Why?
|
Databases, Factual | 14 | 2022 | 8061 | 0.770 |
Why?
|
Programming Languages | 5 | 2017 | 133 | 0.740 |
Why?
|
Biological Specimen Banks | 2 | 2022 | 788 | 0.730 |
Why?
|
Database Management Systems | 3 | 2014 | 263 | 0.690 |
Why?
|
Pattern Recognition, Automated | 4 | 2022 | 978 | 0.640 |
Why?
|
Medical Informatics Computing | 1 | 2018 | 23 | 0.620 |
Why?
|
Genomics | 12 | 2023 | 5924 | 0.620 |
Why?
|
Vocabulary, Controlled | 5 | 2018 | 170 | 0.610 |
Why?
|
ROC Curve | 8 | 2021 | 3616 | 0.580 |
Why?
|
Internet | 7 | 2018 | 3111 | 0.560 |
Why?
|
Humans | 188 | 2024 | 766432 | 0.560 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2024 | 1374 | 0.550 |
Why?
|
Colitis, Ulcerative | 7 | 2019 | 1918 | 0.520 |
Why?
|
Crohn Disease | 7 | 2019 | 2285 | 0.500 |
Why?
|
Disease | 1 | 2021 | 675 | 0.500 |
Why?
|
Current Procedural Terminology | 1 | 2015 | 101 | 0.480 |
Why?
|
Confidentiality | 5 | 2019 | 607 | 0.480 |
Why?
|
Cluster Analysis | 3 | 2023 | 2718 | 0.460 |
Why?
|
Learning | 1 | 2024 | 1754 | 0.460 |
Why?
|
Vulnerable Populations | 1 | 2019 | 717 | 0.430 |
Why?
|
Information Systems | 2 | 2014 | 400 | 0.420 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2024 | 1641 | 0.420 |
Why?
|
International Classification of Diseases | 8 | 2019 | 935 | 0.410 |
Why?
|
Health Level Seven | 3 | 2018 | 35 | 0.400 |
Why?
|
Immunoglobulin G | 1 | 2024 | 4559 | 0.400 |
Why?
|
Hospitalization | 13 | 2022 | 10812 | 0.400 |
Why?
|
Continuity of Patient Care | 3 | 2021 | 1075 | 0.400 |
Why?
|
Phenotype | 20 | 2023 | 16721 | 0.400 |
Why?
|
Computational Biology | 6 | 2013 | 3564 | 0.400 |
Why?
|
Registries | 9 | 2020 | 8344 | 0.400 |
Why?
|
Arthritis, Rheumatoid | 12 | 2018 | 3788 | 0.380 |
Why?
|
Anterior Cerebral Artery | 2 | 2021 | 50 | 0.360 |
Why?
|
Radiology Information Systems | 1 | 2015 | 535 | 0.350 |
Why?
|
Echocardiography | 2 | 2018 | 5030 | 0.350 |
Why?
|
Subarachnoid Hemorrhage | 4 | 2019 | 1023 | 0.350 |
Why?
|
Data Collection | 6 | 2023 | 3321 | 0.340 |
Why?
|
Unified Medical Language System | 4 | 2019 | 88 | 0.340 |
Why?
|
Data Interpretation, Statistical | 2 | 2019 | 2693 | 0.330 |
Why?
|
Basilar Artery | 2 | 2021 | 207 | 0.330 |
Why?
|
Point-of-Care Systems | 1 | 2018 | 1217 | 0.330 |
Why?
|
Adverse Drug Reaction Reporting Systems | 3 | 2011 | 497 | 0.330 |
Why?
|
Computer Security | 6 | 2021 | 261 | 0.330 |
Why?
|
Biology | 2 | 2022 | 293 | 0.320 |
Why?
|
Models, Statistical | 2 | 2021 | 5089 | 0.320 |
Why?
|
Retrospective Studies | 30 | 2024 | 81588 | 0.320 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2018 | 4348 | 0.320 |
Why?
|
Medical Subject Headings | 1 | 2008 | 16 | 0.320 |
Why?
|
Clostridium Infections | 2 | 2014 | 563 | 0.310 |
Why?
|
Community Networks | 2 | 2019 | 202 | 0.310 |
Why?
|
Cohort Studies | 30 | 2024 | 41703 | 0.290 |
Why?
|
Artificial Intelligence | 5 | 2022 | 2660 | 0.290 |
Why?
|
Search Engine | 1 | 2008 | 142 | 0.280 |
Why?
|
Comparative Effectiveness Research | 3 | 2018 | 713 | 0.270 |
Why?
|
Electronics | 2 | 2023 | 315 | 0.270 |
Why?
|
Image Processing, Computer-Assisted | 8 | 2021 | 8925 | 0.270 |
Why?
|
Circle of Willis | 3 | 2021 | 77 | 0.260 |
Why?
|
Severity of Illness Index | 4 | 2021 | 15897 | 0.260 |
Why?
|
Ventricular Function, Left | 1 | 2018 | 3919 | 0.250 |
Why?
|
Stroke Volume | 2 | 2019 | 5583 | 0.250 |
Why?
|
Middle Aged | 59 | 2024 | 223127 | 0.240 |
Why?
|
Comorbidity | 7 | 2020 | 10579 | 0.230 |
Why?
|
Cerebral Angiography | 5 | 2021 | 1263 | 0.230 |
Why?
|
Male | 77 | 2024 | 363975 | 0.230 |
Why?
|
Female | 83 | 2024 | 396354 | 0.230 |
Why?
|
Academic Medical Centers | 2 | 2012 | 2782 | 0.230 |
Why?
|
Delivery of Health Care | 5 | 2023 | 5367 | 0.220 |
Why?
|
Patient-Centered Care | 1 | 2014 | 1447 | 0.220 |
Why?
|
Terminology as Topic | 2 | 2008 | 1539 | 0.220 |
Why?
|
Logical Observation Identifiers Names and Codes | 2 | 2022 | 16 | 0.220 |
Why?
|
Reproducibility of Results | 9 | 2022 | 20129 | 0.220 |
Why?
|
Adult | 54 | 2024 | 223253 | 0.210 |
Why?
|
Hypoglycemic Agents | 4 | 2024 | 3107 | 0.210 |
Why?
|
Hospital Information Systems | 6 | 2012 | 395 | 0.210 |
Why?
|
Aged | 45 | 2024 | 171234 | 0.210 |
Why?
|
Quality Indicators, Health Care | 1 | 2013 | 1804 | 0.210 |
Why?
|
United States | 25 | 2022 | 72910 | 0.210 |
Why?
|
Agammaglobulinemia | 1 | 2024 | 173 | 0.210 |
Why?
|
Calcium | 8 | 2018 | 5781 | 0.210 |
Why?
|
Gastrointestinal Agents | 2 | 2018 | 511 | 0.200 |
Why?
|
Depressive Disorder, Major | 6 | 2020 | 4810 | 0.200 |
Why?
|
Prognosis | 10 | 2021 | 29922 | 0.200 |
Why?
|
Pandemics | 5 | 2022 | 8729 | 0.200 |
Why?
|
Genome-Wide Association Study | 7 | 2022 | 12807 | 0.200 |
Why?
|
Immunization, Passive | 1 | 2024 | 618 | 0.200 |
Why?
|
Case-Control Studies | 16 | 2021 | 22245 | 0.190 |
Why?
|
Diagnostic Imaging | 4 | 2022 | 3530 | 0.190 |
Why?
|
Diabetes Mellitus, Type 2 | 5 | 2024 | 12236 | 0.190 |
Why?
|
Alzheimer Disease | 1 | 2023 | 8716 | 0.190 |
Why?
|
Hypertension | 4 | 2023 | 8614 | 0.190 |
Why?
|
Risk Factors | 30 | 2024 | 74828 | 0.180 |
Why?
|
Vitamin D | 4 | 2015 | 3270 | 0.170 |
Why?
|
Receptors, Neurotransmitter | 3 | 1989 | 171 | 0.170 |
Why?
|
Logistic Models | 15 | 2020 | 13276 | 0.170 |
Why?
|
Middle Cerebral Artery | 1 | 2021 | 271 | 0.170 |
Why?
|
Massachusetts | 7 | 2023 | 8885 | 0.170 |
Why?
|
Risk Assessment | 10 | 2023 | 24272 | 0.170 |
Why?
|
Polymorphism, Single Nucleotide | 9 | 2022 | 16042 | 0.170 |
Why?
|
Personal Satisfaction | 1 | 2024 | 642 | 0.160 |
Why?
|
Dipeptidyl-Peptidase IV Inhibitors | 1 | 2023 | 317 | 0.160 |
Why?
|
Georgia | 1 | 2019 | 186 | 0.160 |
Why?
|
Color | 1 | 2020 | 297 | 0.160 |
Why?
|
Probability | 2 | 2021 | 2475 | 0.150 |
Why?
|
Diabetes Mellitus | 5 | 2022 | 5883 | 0.150 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 3 | 2023 | 3245 | 0.150 |
Why?
|
Antidepressive Agents | 4 | 2014 | 2902 | 0.150 |
Why?
|
Hypertension, Pulmonary | 2 | 2020 | 1604 | 0.150 |
Why?
|
Drug Therapy | 1 | 2021 | 504 | 0.150 |
Why?
|
Multivariate Analysis | 9 | 2020 | 12061 | 0.150 |
Why?
|
Heart Failure | 2 | 2019 | 11816 | 0.140 |
Why?
|
Age Factors | 7 | 2021 | 18395 | 0.140 |
Why?
|
Patients | 1 | 2024 | 908 | 0.140 |
Why?
|
Diagnostic Tests, Routine | 2 | 2021 | 789 | 0.140 |
Why?
|
Health Services Research | 2 | 2009 | 1811 | 0.140 |
Why?
|
Metformin | 1 | 2024 | 906 | 0.140 |
Why?
|
Heroin Dependence | 1 | 2017 | 174 | 0.130 |
Why?
|
Research Design | 3 | 2019 | 6205 | 0.130 |
Why?
|
International Normalized Ratio | 1 | 2018 | 381 | 0.130 |
Why?
|
Aged, 80 and over | 9 | 2024 | 59538 | 0.130 |
Why?
|
Asthma | 4 | 2009 | 6267 | 0.130 |
Why?
|
Magnesium | 2 | 2018 | 815 | 0.130 |
Why?
|
Insurance Claim Review | 1 | 2020 | 744 | 0.130 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2019 | 359 | 0.130 |
Why?
|
New England | 5 | 2022 | 1059 | 0.130 |
Why?
|
Hypercholesterolemia | 1 | 2023 | 1145 | 0.130 |
Why?
|
Professional-Patient Relations | 1 | 2021 | 724 | 0.130 |
Why?
|
Glutamates | 4 | 1989 | 384 | 0.120 |
Why?
|
TYK2 Kinase | 1 | 2015 | 38 | 0.120 |
Why?
|
Longitudinal Studies | 5 | 2024 | 14760 | 0.120 |
Why?
|
Brain | 8 | 2021 | 27156 | 0.120 |
Why?
|
Quality Control | 1 | 2018 | 834 | 0.120 |
Why?
|
Depressive Disorder | 3 | 2013 | 3714 | 0.120 |
Why?
|
Autoantibodies | 3 | 2013 | 2115 | 0.120 |
Why?
|
Genome | 1 | 2023 | 1751 | 0.120 |
Why?
|
Practice Guidelines as Topic | 3 | 2019 | 7426 | 0.120 |
Why?
|
Kainic Acid | 3 | 1989 | 203 | 0.120 |
Why?
|
Arthralgia | 1 | 2018 | 459 | 0.120 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2017 | 2808 | 0.110 |
Why?
|
C-Reactive Protein | 2 | 2018 | 3852 | 0.110 |
Why?
|
Vitamin D Deficiency | 2 | 2013 | 1348 | 0.110 |
Why?
|
Mendelian Randomization Analysis | 1 | 2020 | 1044 | 0.110 |
Why?
|
Minority Groups | 1 | 2021 | 1208 | 0.110 |
Why?
|
High-Throughput Screening Assays | 1 | 2019 | 938 | 0.110 |
Why?
|
Genetic Pleiotropy | 1 | 2015 | 182 | 0.110 |
Why?
|
Hypolipidemic Agents | 1 | 2018 | 609 | 0.110 |
Why?
|
Hypersensitivity | 1 | 2022 | 1169 | 0.110 |
Why?
|
Sensitivity and Specificity | 5 | 2021 | 14643 | 0.110 |
Why?
|
Longevity | 1 | 2021 | 1085 | 0.110 |
Why?
|
Organizations | 1 | 2014 | 172 | 0.110 |
Why?
|
Decision Support Systems, Clinical | 1 | 2022 | 1178 | 0.110 |
Why?
|
Anticoagulants | 3 | 2020 | 4844 | 0.100 |
Why?
|
Blood Sedimentation | 1 | 2014 | 234 | 0.100 |
Why?
|
Respiratory Function Tests | 2 | 2007 | 1691 | 0.100 |
Why?
|
Respiration, Artificial | 2 | 2021 | 2727 | 0.100 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2014 | 427 | 0.100 |
Why?
|
Computer Systems | 3 | 2011 | 467 | 0.100 |
Why?
|
Lipid Metabolism | 1 | 2020 | 1896 | 0.100 |
Why?
|
Corpus Striatum | 2 | 1989 | 1218 | 0.100 |
Why?
|
Genetic Predisposition to Disease | 9 | 2022 | 18075 | 0.100 |
Why?
|
Cholangitis, Sclerosing | 1 | 2014 | 179 | 0.100 |
Why?
|
Organizational Innovation | 1 | 2015 | 540 | 0.100 |
Why?
|
Magnetic Resonance Imaging | 5 | 2021 | 36562 | 0.100 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2019 | 3724 | 0.100 |
Why?
|
Antibodies, Antinuclear | 1 | 2013 | 340 | 0.090 |
Why?
|
Cholesterol, HDL | 1 | 2018 | 1812 | 0.090 |
Why?
|
Anxiety Disorders | 2 | 2013 | 2744 | 0.090 |
Why?
|
Myelin Sheath | 1 | 2015 | 650 | 0.090 |
Why?
|
Prospective Studies | 9 | 2023 | 54826 | 0.090 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2014 | 490 | 0.090 |
Why?
|
Health Insurance Portability and Accountability Act | 1 | 2011 | 104 | 0.090 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2018 | 3249 | 0.090 |
Why?
|
Sjogren's Syndrome | 1 | 2013 | 240 | 0.090 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2015 | 463 | 0.090 |
Why?
|
Odds Ratio | 6 | 2020 | 9654 | 0.090 |
Why?
|
Obesity, Morbid | 1 | 2021 | 1292 | 0.090 |
Why?
|
Colorectal Neoplasms | 3 | 2016 | 6962 | 0.090 |
Why?
|
Patient Selection | 1 | 2003 | 4248 | 0.090 |
Why?
|
Bipolar Disorder | 3 | 2018 | 5130 | 0.090 |
Why?
|
Parturition | 1 | 2014 | 453 | 0.090 |
Why?
|
Paroxetine | 1 | 2011 | 181 | 0.090 |
Why?
|
Iron | 1 | 2019 | 1812 | 0.090 |
Why?
|
Drug Therapy, Combination | 2 | 2020 | 6306 | 0.090 |
Why?
|
Lipoproteins, LDL | 1 | 2013 | 642 | 0.080 |
Why?
|
Warfarin | 1 | 2018 | 1488 | 0.080 |
Why?
|
Area Under Curve | 3 | 2019 | 1638 | 0.080 |
Why?
|
Hospital Shared Services | 1 | 2009 | 16 | 0.080 |
Why?
|
Delirium | 1 | 2021 | 1698 | 0.080 |
Why?
|
Limbic System | 1 | 2012 | 418 | 0.080 |
Why?
|
Angiography, Digital Subtraction | 2 | 2021 | 331 | 0.080 |
Why?
|
Pravastatin | 1 | 2011 | 391 | 0.080 |
Why?
|
Telemedicine | 2 | 2019 | 3110 | 0.080 |
Why?
|
Decision Support Techniques | 2 | 2020 | 2007 | 0.080 |
Why?
|
Immunologic Factors | 2 | 2015 | 1594 | 0.080 |
Why?
|
Lipoproteins | 1 | 2013 | 871 | 0.080 |
Why?
|
Time Factors | 5 | 2021 | 40116 | 0.080 |
Why?
|
Aspartic Acid | 2 | 1989 | 575 | 0.080 |
Why?
|
Suicide | 1 | 2020 | 1606 | 0.080 |
Why?
|
Serum Albumin | 1 | 2012 | 675 | 0.080 |
Why?
|
Follow-Up Studies | 8 | 2019 | 39283 | 0.080 |
Why?
|
Models, Theoretical | 2 | 2018 | 3562 | 0.080 |
Why?
|
Infant, Newborn | 8 | 2021 | 26388 | 0.070 |
Why?
|
Bayes Theorem | 3 | 2022 | 2352 | 0.070 |
Why?
|
Hypothyroidism | 1 | 2013 | 665 | 0.070 |
Why?
|
Risk | 5 | 2020 | 9601 | 0.070 |
Why?
|
Thromboembolism | 1 | 2014 | 1001 | 0.070 |
Why?
|
Intensive Care Units | 1 | 2021 | 3798 | 0.070 |
Why?
|
Genotype | 5 | 2015 | 13034 | 0.070 |
Why?
|
Delivery, Obstetric | 1 | 2014 | 948 | 0.070 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2012 | 597 | 0.070 |
Why?
|
Autoimmunity | 1 | 2015 | 1356 | 0.070 |
Why?
|
Incidence | 7 | 2024 | 21509 | 0.070 |
Why?
|
Blood Pressure | 2 | 2023 | 8532 | 0.070 |
Why?
|
Colectomy | 1 | 2012 | 696 | 0.070 |
Why?
|
Accidental Falls | 1 | 2014 | 1078 | 0.070 |
Why?
|
Hippocampus | 3 | 1989 | 3776 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 1 | 2016 | 1805 | 0.070 |
Why?
|
Myoblasts, Skeletal | 1 | 2006 | 74 | 0.070 |
Why?
|
Young Adult | 10 | 2021 | 59928 | 0.070 |
Why?
|
Goals | 1 | 2011 | 717 | 0.070 |
Why?
|
Chi-Square Distribution | 2 | 2014 | 3427 | 0.070 |
Why?
|
Creatinine | 1 | 2012 | 1916 | 0.070 |
Why?
|
Colonoscopy | 1 | 2014 | 1409 | 0.060 |
Why?
|
Proportional Hazards Models | 3 | 2022 | 12527 | 0.060 |
Why?
|
Hemoglobins | 1 | 2012 | 1531 | 0.060 |
Why?
|
Dyslipidemias | 1 | 2013 | 871 | 0.060 |
Why?
|
Smoking | 3 | 2020 | 9076 | 0.060 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2018 | 1657 | 0.060 |
Why?
|
Smoking Cessation | 1 | 2017 | 2082 | 0.060 |
Why?
|
Cesarean Section | 1 | 2014 | 1418 | 0.060 |
Why?
|
Information Management | 1 | 2006 | 100 | 0.060 |
Why?
|
Child, Preschool | 9 | 2021 | 42576 | 0.060 |
Why?
|
Genetic Testing | 1 | 2018 | 3590 | 0.060 |
Why?
|
Psychotic Disorders | 1 | 2020 | 3275 | 0.060 |
Why?
|
Brain Injuries | 1 | 2017 | 2053 | 0.060 |
Why?
|
DNA Copy Number Variations | 1 | 2014 | 2043 | 0.060 |
Why?
|
Genetic Association Studies | 1 | 2014 | 2746 | 0.060 |
Why?
|
Quisqualic Acid | 3 | 1989 | 35 | 0.060 |
Why?
|
Body Mass Index | 5 | 2021 | 13045 | 0.060 |
Why?
|
Referral and Consultation | 1 | 1998 | 3616 | 0.060 |
Why?
|
Amino Acids | 2 | 1987 | 1711 | 0.060 |
Why?
|
Health Care Surveys | 1 | 2012 | 2425 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2017 | 4045 | 0.060 |
Why?
|
Oxadiazoles | 3 | 1989 | 94 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2024 | 65202 | 0.060 |
Why?
|
Models, Genetic | 1 | 2014 | 3450 | 0.060 |
Why?
|
Postoperative Complications | 2 | 2020 | 15818 | 0.060 |
Why?
|
Infant | 7 | 2021 | 36460 | 0.060 |
Why?
|
Weight Gain | 1 | 2014 | 2356 | 0.060 |
Why?
|
Obesity | 3 | 2022 | 13088 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2022 | 5097 | 0.050 |
Why?
|
Boston | 5 | 2016 | 9333 | 0.050 |
Why?
|
Child | 11 | 2022 | 80668 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 3 | 2021 | 4047 | 0.050 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2006 | 553 | 0.050 |
Why?
|
Arrhythmias, Cardiac | 1 | 2013 | 2246 | 0.050 |
Why?
|
Predictive Value of Tests | 3 | 2017 | 15390 | 0.050 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 2270 | 0.050 |
Why?
|
Lipids | 1 | 2013 | 3319 | 0.050 |
Why?
|
Forecasting | 1 | 2011 | 2935 | 0.050 |
Why?
|
Quality Improvement | 2 | 2015 | 3849 | 0.050 |
Why?
|
Sulfonylurea Compounds | 1 | 2023 | 220 | 0.050 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2014 | 2538 | 0.050 |
Why?
|
Wounds and Injuries | 1 | 2014 | 2513 | 0.050 |
Why?
|
Brain Mapping | 1 | 2017 | 6596 | 0.050 |
Why?
|
Calcium Channels | 3 | 1990 | 622 | 0.050 |
Why?
|
Knowledge Bases | 1 | 2022 | 96 | 0.050 |
Why?
|
Diffusion Tensor Imaging | 1 | 2012 | 2418 | 0.050 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2006 | 844 | 0.050 |
Why?
|
Comoros | 1 | 2020 | 12 | 0.050 |
Why?
|
Adolescent | 9 | 2021 | 88898 | 0.050 |
Why?
|
Health Policy | 1 | 2013 | 2698 | 0.050 |
Why?
|
Cholesterol, LDL | 2 | 2023 | 2392 | 0.050 |
Why?
|
Disease Progression | 4 | 2023 | 13632 | 0.050 |
Why?
|
Computer Graphics | 1 | 2003 | 345 | 0.040 |
Why?
|
Prevalence | 4 | 2021 | 15820 | 0.040 |
Why?
|
Patient Acceptance of Health Care | 1 | 2014 | 3230 | 0.040 |
Why?
|
Health Services Accessibility | 1 | 2018 | 5509 | 0.040 |
Why?
|
Propensity Score | 2 | 2018 | 1972 | 0.040 |
Why?
|
Neurons | 3 | 1988 | 9515 | 0.040 |
Why?
|
Privacy | 1 | 2022 | 233 | 0.040 |
Why?
|
Mental Disorders | 1 | 2020 | 6869 | 0.040 |
Why?
|
National Human Genome Research Institute (U.S.) | 1 | 2019 | 22 | 0.040 |
Why?
|
Electrocardiography | 1 | 2013 | 6378 | 0.040 |
Why?
|
Peptides, Cyclic | 2 | 2013 | 390 | 0.040 |
Why?
|
Ethics Committees, Research | 1 | 2021 | 196 | 0.040 |
Why?
|
Pituitary Gland, Anterior | 2 | 1990 | 142 | 0.040 |
Why?
|
Aortic Aneurysm | 1 | 2024 | 649 | 0.040 |
Why?
|
Automation | 1 | 2021 | 586 | 0.040 |
Why?
|
Psychiatry | 1 | 2011 | 1714 | 0.040 |
Why?
|
Vital Capacity | 1 | 2021 | 995 | 0.040 |
Why?
|
Colestipol | 1 | 2018 | 10 | 0.040 |
Why?
|
Cooperative Behavior | 1 | 2006 | 1512 | 0.040 |
Why?
|
Multiple Sclerosis | 1 | 2013 | 3229 | 0.040 |
Why?
|
Cholestyramine Resin | 1 | 2018 | 25 | 0.040 |
Why?
|
Fibric Acids | 1 | 2018 | 27 | 0.040 |
Why?
|
Psychomotor Agitation | 1 | 2020 | 307 | 0.040 |
Why?
|
N-Methylaspartate | 2 | 1989 | 231 | 0.040 |
Why?
|
Peer Review, Research | 1 | 2021 | 343 | 0.040 |
Why?
|
Rupture, Spontaneous | 1 | 2018 | 362 | 0.040 |
Why?
|
Sex Factors | 3 | 2020 | 10614 | 0.040 |
Why?
|
Models, Biological | 1 | 2013 | 9458 | 0.040 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2020 | 418 | 0.040 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2021 | 792 | 0.040 |
Why?
|
Drug Interactions | 2 | 2012 | 1419 | 0.030 |
Why?
|
Lipase | 1 | 2019 | 320 | 0.030 |
Why?
|
Insurance Claim Reporting | 1 | 2017 | 166 | 0.030 |
Why?
|
Cardiovascular Diseases | 2 | 2020 | 15639 | 0.030 |
Why?
|
Cross-Sectional Studies | 5 | 2018 | 26294 | 0.030 |
Why?
|
Workflow | 1 | 2021 | 859 | 0.030 |
Why?
|
Blood Glucose | 1 | 2011 | 6422 | 0.030 |
Why?
|
Government Regulation | 1 | 2021 | 525 | 0.030 |
Why?
|
Forced Expiratory Volume | 1 | 2021 | 1828 | 0.030 |
Why?
|
Ferritins | 1 | 2019 | 600 | 0.030 |
Why?
|
Documentation | 1 | 2022 | 914 | 0.030 |
Why?
|
Fatigue | 1 | 2023 | 1554 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2015 | 6543 | 0.030 |
Why?
|
Organ Size | 1 | 2020 | 2261 | 0.030 |
Why?
|
Methods | 1 | 1996 | 1065 | 0.030 |
Why?
|
Oligonucleotides | 1 | 2018 | 561 | 0.030 |
Why?
|
Monitoring, Physiologic | 1 | 2022 | 1794 | 0.030 |
Why?
|
Neoplasms | 2 | 2014 | 22343 | 0.030 |
Why?
|
Drug Utilization | 1 | 2020 | 1187 | 0.030 |
Why?
|
Nortriptyline | 1 | 2014 | 79 | 0.030 |
Why?
|
Amitriptyline | 1 | 2014 | 110 | 0.030 |
Why?
|
Rectal Fistula | 1 | 2014 | 76 | 0.030 |
Why?
|
Atlases as Topic | 1 | 2015 | 247 | 0.030 |
Why?
|
Skull | 1 | 2018 | 819 | 0.030 |
Why?
|
Morbidity | 1 | 2019 | 1753 | 0.030 |
Why?
|
Dwarfism | 1 | 1975 | 137 | 0.030 |
Why?
|
Mass Screening | 1 | 2009 | 5451 | 0.030 |
Why?
|
Nitrendipine | 2 | 1990 | 12 | 0.030 |
Why?
|
Medicare | 2 | 2022 | 6817 | 0.030 |
Why?
|
Publishing | 1 | 2021 | 837 | 0.030 |
Why?
|
Pharmacies | 1 | 2015 | 171 | 0.030 |
Why?
|
Genetic Research | 1 | 2014 | 173 | 0.030 |
Why?
|
Glutamic Acid | 2 | 1989 | 1181 | 0.030 |
Why?
|
Hospitals, General | 1 | 1998 | 803 | 0.030 |
Why?
|
Patient Discharge | 1 | 2006 | 3465 | 0.030 |
Why?
|
England | 1 | 2014 | 533 | 0.030 |
Why?
|
Medical Audit | 1 | 2014 | 454 | 0.030 |
Why?
|
Cost of Illness | 1 | 2022 | 1949 | 0.030 |
Why?
|
Benzimidazoles | 1 | 2018 | 861 | 0.030 |
Why?
|
Thyroiditis | 1 | 2013 | 86 | 0.030 |
Why?
|
Patient Access to Records | 1 | 2013 | 120 | 0.030 |
Why?
|
Bupropion | 1 | 2014 | 303 | 0.030 |
Why?
|
Fornix, Brain | 1 | 2012 | 71 | 0.020 |
Why?
|
Sex Ratio | 1 | 2012 | 107 | 0.020 |
Why?
|
Heart Diseases | 1 | 2005 | 2814 | 0.020 |
Why?
|
Transglutaminases | 1 | 2013 | 200 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1884 | 0.020 |
Why?
|
Seroepidemiologic Studies | 1 | 2013 | 404 | 0.020 |
Why?
|
Citalopram | 1 | 2014 | 402 | 0.020 |
Why?
|
Iodide Peroxidase | 1 | 2013 | 295 | 0.020 |
Why?
|
Biological Products | 1 | 2020 | 948 | 0.020 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2015 | 391 | 0.020 |
Why?
|
Organizational Policy | 1 | 2013 | 434 | 0.020 |
Why?
|
Feasibility Studies | 2 | 2012 | 5302 | 0.020 |
Why?
|
Sample Size | 1 | 2014 | 844 | 0.020 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2014 | 520 | 0.020 |
Why?
|
Nutrition Surveys | 1 | 2018 | 1735 | 0.020 |
Why?
|
Attention | 1 | 2021 | 2413 | 0.020 |
Why?
|
Dihydropyridines | 2 | 1988 | 67 | 0.020 |
Why?
|
Mother-Child Relations | 1 | 2014 | 498 | 0.020 |
Why?
|
Hyperlipidemias | 1 | 2015 | 771 | 0.020 |
Why?
|
Cells, Cultured | 5 | 2006 | 18979 | 0.020 |
Why?
|
Hospitals, University | 1 | 2012 | 571 | 0.020 |
Why?
|
Survival Analysis | 1 | 2022 | 10092 | 0.020 |
Why?
|
6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 1989 | 55 | 0.020 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2020 | 1480 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2015 | 932 | 0.020 |
Why?
|
Inositol 1,4,5-Trisphosphate | 1 | 1989 | 110 | 0.020 |
Why?
|
Digestive System Surgical Procedures | 1 | 2014 | 584 | 0.020 |
Why?
|
Exons | 1 | 2015 | 2392 | 0.020 |
Why?
|
Ibotenic Acid | 1 | 1988 | 59 | 0.020 |
Why?
|
Inositol Phosphates | 1 | 1989 | 175 | 0.020 |
Why?
|
Homeostasis | 2 | 2011 | 3341 | 0.020 |
Why?
|
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 1988 | 70 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 2015 | 1612 | 0.020 |
Why?
|
Myocardial Infarction | 1 | 2009 | 11501 | 0.020 |
Why?
|
GTP-Binding Proteins | 1 | 2013 | 946 | 0.020 |
Why?
|
Anisotropy | 1 | 2012 | 1285 | 0.020 |
Why?
|
Methotrexate | 1 | 2015 | 1719 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2015 | 1457 | 0.020 |
Why?
|
Ion Channel Gating | 1 | 1990 | 428 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2020 | 3068 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3885 | 0.020 |
Why?
|
Dibenzocycloheptenes | 1 | 1987 | 27 | 0.020 |
Why?
|
Follicle Stimulating Hormone | 1 | 1990 | 731 | 0.020 |
Why?
|
Receptors, Glutamate | 1 | 1988 | 228 | 0.020 |
Why?
|
Potassium | 2 | 1989 | 1314 | 0.020 |
Why?
|
Luteinizing Hormone | 1 | 1990 | 828 | 0.020 |
Why?
|
Animals | 9 | 2007 | 168887 | 0.020 |
Why?
|
Receptors, AMPA | 1 | 1989 | 334 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2018 | 4779 | 0.020 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2014 | 889 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2012 | 811 | 0.020 |
Why?
|
Quinoxalines | 1 | 1989 | 296 | 0.020 |
Why?
|
Virginia | 1 | 2007 | 115 | 0.020 |
Why?
|
Calcium Channel Blockers | 1 | 1990 | 687 | 0.020 |
Why?
|
Indiana | 1 | 2007 | 93 | 0.020 |
Why?
|
Birth Weight | 1 | 1975 | 2123 | 0.020 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2012 | 951 | 0.020 |
Why?
|
Bone Morphogenetic Protein Receptors, Type I | 1 | 2006 | 97 | 0.020 |
Why?
|
Bone Morphogenetic Protein 4 | 1 | 2006 | 163 | 0.020 |
Why?
|
Gonadotropin-Releasing Hormone | 2 | 1990 | 1142 | 0.020 |
Why?
|
Remission Induction | 1 | 2012 | 2413 | 0.020 |
Why?
|
Gyrus Cinguli | 1 | 2012 | 1118 | 0.020 |
Why?
|
Peptides | 1 | 2018 | 4344 | 0.020 |
Why?
|
Genetic Loci | 1 | 2015 | 2630 | 0.020 |
Why?
|
Permeability | 1 | 1987 | 728 | 0.020 |
Why?
|
Anxiety | 1 | 2020 | 4671 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2018 | 4215 | 0.020 |
Why?
|
Pennsylvania | 1 | 2007 | 615 | 0.020 |
Why?
|
Genome, Human | 1 | 2018 | 4443 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2009 | 1186 | 0.010 |
Why?
|
Patient Participation | 1 | 2013 | 1446 | 0.010 |
Why?
|
Alleles | 1 | 2015 | 6894 | 0.010 |
Why?
|
Glycine | 1 | 1987 | 671 | 0.010 |
Why?
|
Kinetics | 2 | 1988 | 6285 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6508 | 0.010 |
Why?
|
Gene Frequency | 1 | 2011 | 3624 | 0.010 |
Why?
|
Sodium | 1 | 1989 | 1593 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 8042 | 0.010 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 1989 | 903 | 0.010 |
Why?
|
Drug Monitoring | 1 | 2009 | 960 | 0.010 |
Why?
|
Rats, Inbred Strains | 3 | 1990 | 2078 | 0.010 |
Why?
|
Diabetes Complications | 1 | 2009 | 1317 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 1988 | 1675 | 0.010 |
Why?
|
United States Food and Drug Administration | 1 | 2011 | 1673 | 0.010 |
Why?
|
Pregnancy | 2 | 2014 | 30235 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2012 | 6020 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2019 | 7866 | 0.010 |
Why?
|
Mice | 5 | 1989 | 81863 | 0.010 |
Why?
|
Quality Assurance, Health Care | 1 | 2012 | 2170 | 0.010 |
Why?
|
Research | 1 | 2010 | 1977 | 0.010 |
Why?
|
Ion Channels | 1 | 1986 | 1043 | 0.010 |
Why?
|
Mice, Inbred C57BL | 3 | 1989 | 22337 | 0.010 |
Why?
|
Societies, Medical | 1 | 2013 | 3953 | 0.010 |
Why?
|
Primary Health Care | 1 | 1998 | 4734 | 0.010 |
Why?
|
Computer Simulation | 1 | 2014 | 6259 | 0.010 |
Why?
|
Genetic Variation | 1 | 2015 | 6612 | 0.010 |
Why?
|
Patient Readmission | 1 | 2014 | 3282 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2011 | 2778 | 0.010 |
Why?
|
Survival Rate | 1 | 2014 | 12825 | 0.010 |
Why?
|
Synapses | 1 | 1989 | 1759 | 0.010 |
Why?
|
Pilot Projects | 1 | 2012 | 8720 | 0.010 |
Why?
|
Fetus | 1 | 2006 | 1878 | 0.010 |
Why?
|
Inflammation | 1 | 2018 | 10860 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 1987 | 2815 | 0.010 |
Why?
|
Software Design | 1 | 1998 | 173 | 0.010 |
Why?
|
Decision Making, Computer-Assisted | 1 | 1998 | 146 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2011 | 7840 | 0.010 |
Why?
|
Signal Transduction | 1 | 2019 | 23611 | 0.010 |
Why?
|
Reminder Systems | 1 | 1998 | 388 | 0.010 |
Why?
|
Pyridines | 1 | 1986 | 2888 | 0.010 |
Why?
|
Depression | 1 | 2013 | 8229 | 0.010 |
Why?
|
Consanguinity | 1 | 1975 | 460 | 0.010 |
Why?
|
Rats | 4 | 1990 | 23718 | 0.010 |
Why?
|
omega-Conotoxin GVIA | 1 | 1990 | 19 | 0.010 |
Why?
|
Secretory Rate | 1 | 1990 | 82 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2006 | 10438 | 0.010 |
Why?
|
Syndrome | 1 | 1975 | 3271 | 0.000 |
Why?
|
Receptors, Amino Acid | 1 | 1987 | 30 | 0.000 |
Why?
|
Phencyclidine | 1 | 1987 | 59 | 0.000 |
Why?
|
Convulsants | 1 | 1987 | 70 | 0.000 |
Why?
|
Dizocilpine Maleate | 1 | 1987 | 171 | 0.000 |
Why?
|
Abnormalities, Multiple | 1 | 1975 | 1424 | 0.000 |
Why?
|
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 1 | 1986 | 34 | 0.000 |
Why?
|
Membrane Potentials | 1 | 1990 | 1085 | 0.000 |
Why?
|
Pedigree | 1 | 1975 | 4537 | 0.000 |
Why?
|
Cytosol | 1 | 1986 | 886 | 0.000 |
Why?
|
Organ Specificity | 1 | 1986 | 1966 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1975 | 12979 | 0.000 |
Why?
|
Cell Membrane | 1 | 1987 | 3640 | 0.000 |
Why?
|